Skip to main content

Table 4 Regression outputs of implementation fidelity and its determinants

From: Clinical guidelines for managing hearing loss as a complication of drug-resistant tuberculosis treatment: an evaluation of implementation fidelity in Kano, Nigeria

Factors

Unadjusted Model

Adjusted (R2 = 76.64)

Coefficient

95% Cl

Coefficient

95% CI

Facilitation strategies

0.18

−0.31-0.68

−0.64a

−1.23--0.05

Quality of delivery

1.91a

1.11–2.71

1.15a

0 .17–2.12

Intervention complexity

−0.69

−1.65 - 0.27

1.24a

0.53–1.95

Participants’ responsiveness

3.82a

2.07–5.56

0.57

−1.88 -3.01

Age

0 .32

−1.76 -2.41

−1.13

− 1.13

Work experience

0.45

−0.29 - 1.21

−0.14

− 0.14

Sex

 Female (Ref)

0.00

 

0.00

 

 Male

10.37a

8.03–12.71

0.67

0.67

Professional Cadre

 Doctors (Ref)

0.00

 

0.00

 

 Nurses

−11.31a

−13.67- -8.95

−12.80a

− 12.80a

 Principal  Clinical Assistant (PCA)

−9.34a

−12.45- -6.24

− 13.25a

− 13.25a

  1. aStatistical significance at 5% level
  2. R2 = the value accounting for the internal variation of implementation fidelity in the model